Labcorp to Pay $14.5 Million to Settle False Claims Act Allegations

MT Newswires Live07-16 06:04

Labcorp (LH) agreed to pay $14.5 million to resolve allegations that it violated the False Claims Act by submitting false claims to Medicare Part B for medically unnecessary urine drug testing conducted under a testing panel marketed as ToxAssure Comprehensive, the Justice Department said Wednesday.

The Justice Department alleged that from 2018 through 2023, Labcorp billed Medicare for both all-inclusive presumptive testing and the highest-tier definitive testing for the same patient on the same date of service and, in some cases, performed definitive tests without first conducting available presumptive tests.

As part of the settlement, Labcorp admitted, acknowledged and accepted responsibility for certain facts described in the agreement and said it has stopped billing Medicare for the combination of codes used with the ToxAssure Comprehensive panel.

The DOJ said the claims resolved by the settlement are allegations only and that there has been no determination of liability.

Labcorp did not immediately respond to a request for comment from MT Newswires.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2651749977?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-16 06:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2651749977","market":"nz","top_or_hot":-1,"title":"Labcorp to Pay $14.5 Million to Settle False Claims Act Allegations","media":"MT Newswires Live","content":"<html><body><p> Labcorp (LH) agreed to pay $14.5 million to resolve allegations that it violated the False Claims Act by submitting false claims to Medicare Part B for medically unnecessary urine drug testing conducted under a testing panel marketed as ToxAssure Comprehensive, the Justice Department said Wednesday.</p><p>The Justice Department alleged that from 2018 through 2023, Labcorp billed Medicare for both all-inclusive presumptive testing and the highest-tier definitive testing for the same patient on the same date of service and, in some cases, performed definitive tests without first conducting available presumptive tests.</p><p>As part of the settlement, Labcorp admitted, acknowledged and accepted responsibility for certain facts described in the agreement and said it has stopped billing Medicare for the combination of codes used with the ToxAssure Comprehensive panel.</p><p>The DOJ said the claims resolved by the settlement are allegations only and that there has been no determination of liability.</p><p>Labcorp did not immediately respond to a request for comment from MT Newswires.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Labcorp to Pay $14.5 Million to Settle False Claims Act Allegations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLabcorp to Pay $14.5 Million to Settle False Claims Act Allegations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-07-16 06:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Labcorp (LH) agreed to pay $14.5 million to resolve allegations that it violated the False Claims Act by submitting false claims to Medicare Part B for medically unnecessary urine drug testing conducted under a testing panel marketed as ToxAssure Comprehensive, the Justice Department said Wednesday.</p><p>The Justice Department alleged that from 2018 through 2023, Labcorp billed Medicare for both all-inclusive presumptive testing and the highest-tier definitive testing for the same patient on the same date of service and, in some cases, performed definitive tests without first conducting available presumptive tests.</p><p>As part of the settlement, Labcorp admitted, acknowledged and accepted responsibility for certain facts described in the agreement and said it has stopped billing Medicare for the combination of codes used with the ToxAssure Comprehensive panel.</p><p>The DOJ said the claims resolved by the settlement are allegations only and that there has been no determination of liability.</p><p>Labcorp did not immediately respond to a request for comment from MT Newswires.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0742534661.SGD","symbol_name":"Fidelity America A-SGD (hedged)","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2651749977","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2651749977","pubTimestamp":1784153064,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Labcorp  agreed to pay $14.5 million to resolve allegations that it violated the False Claims Act by submitting false claims to Medicare Part B for medically unnecessary urine drug testing conducted under a testing panel marketed as ToxAssure Comprehensive, the Justice Department said Wednesday.The Justice Department alleged that from 2018 through 2023, Labcorp billed Medicare for both all-inclusive presumptive testing and the highest-tier definitive testing for the same patient on the same date of service and, in some cases, performed definitive tests without first conducting available presumptive tests.As part of the settlement, Labcorp admitted, acknowledged and accepted responsibility for certain facts described in the agreement and said it has stopped billing Medicare for the combination of codes used with the ToxAssure Comprehensive panel.The DOJ said the claims resolved by the settlement are allegations only and that there has been no determination of liability.Labcorp did not i","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0742534661.SGD":"Fidelity America A-SGD (hedged)","LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","LU0048573561.USD":"FIDELITY AMERICA \"A\" (USD) INC","LU0251142724.SGD":"Fidelity America A-SGD","LU0251131958.USD":"FIDELITY AMERICA \"A\" (USD) ACC","LU1059921491.USD":"NORDEA 1 GLOBAL STABLE EQUITY \"HB\" (USDHDG) ACC","LH":"徕博科","BK4196":"保健护理服务","BK4588":"碎股","BK4550":"红杉资本持仓","BK4585":"ETF&股票定投概念"},"translate_title":"Labcorp 将支付 1,450 万美元来解决《虚假索赔法》指控","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LH":1},"content_text":"Labcorp (LH) agreed to pay $14.5 million to resolve allegations that it violated the False Claims Act by submitting false claims to Medicare Part B for medically unnecessary urine drug testing conducted under a testing panel marketed as ToxAssure Comprehensive, the Justice Department said Wednesday.The Justice Department alleged that from 2018 through 2023, Labcorp billed Medicare for both all-inclusive presumptive testing and the highest-tier definitive testing for the same patient on the same date of service and, in some cases, performed definitive tests without first conducting available presumptive tests.As part of the settlement, Labcorp admitted, acknowledged and accepted responsibility for certain facts described in the agreement and said it has stopped billing Medicare for the combination of codes used with the ToxAssure Comprehensive panel.The DOJ said the claims resolved by the settlement are allegations only and that there has been no determination of liability.Labcorp did not immediately respond to a request for comment from MT Newswires.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2651749977","isCrawlerRequest":true}